As biotechnology exhausts the same narrow set of model organisms, Asperitas delivers exclusive biodiversity access, computational biology, and synthetic engineering to pharma, agriculture, and industrial partners — turning overlooked species into programmable products in months, not decades.
Biotechnology keeps engineering the same narrow set of model organisms — a handful of species asked to solve problems across medicine, agriculture, and industry. Meanwhile, more than eight million species on Earth remain functionally unexplored, each carrying millions of years of chemistry no lab has ever tested.
"The next one hasn't been discovered yet."
The next generation of biotechnology will not be built from a narrow set of model organisms, but from the full diversity of life.
Asperitas is building the discovery and engineering platform to make that future possible.
Nature has already created solutions to problems across medicine, materials, agriculture, and industry.
Our mission is to find them, understand them, and turn them into scalable products.